232 related articles for article (PubMed ID: 9625186)
1. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.
Tilvis RS; Strandberg TE; Juva K
J Am Geriatr Soc; 1998 Jun; 46(6):712-5. PubMed ID: 9625186
[TBL] [Abstract][Full Text] [Related]
2. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704
[TBL] [Abstract][Full Text] [Related]
3. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
4. Dementia among elderly apolipoprotein E type 4/4 homozygotes: a prospective study.
Ganguli M; Cauley JA; DeKosky ST; Kamboh MI
Genet Epidemiol; 1995; 12(3):309-11. PubMed ID: 7557352
[TBL] [Abstract][Full Text] [Related]
5. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
6. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
Yip AG; Brayne C; Easton D; Rubinsztein DC;
J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
[TBL] [Abstract][Full Text] [Related]
8. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
Kuusisto J; Koivisto K; Kervinen K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Pyörälä K; Kesäniemi YA; Riekkinen P
BMJ; 1994 Sep; 309(6955):636-8. PubMed ID: 8086986
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.
Ganguli M; Chandra V; Kamboh MI; Johnston JM; Dodge HH; Thelma BK; Juyal RC; Pandav R; Belle SH; DeKosky ST
Arch Neurol; 2000 Jun; 57(6):824-30. PubMed ID: 10867779
[TBL] [Abstract][Full Text] [Related]
10. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
11. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease.
Olichney JM; Sabbagh MN; Hofstetter CR; Galasko D; Grundman M; Katzman R; Thal LJ
Neurology; 1997 Jul; 49(1):76-81. PubMed ID: 9222173
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
[TBL] [Abstract][Full Text] [Related]
13. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
16. A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.
Skoog I; Waern M; Duberstein P; Blennow K; Zetterberg H; Börjesson-Hanson A; Östling S; Guo X; Kern J; Gustafson D; Gudmundsson P; Marlow T; Kern S
Biol Psychiatry; 2015 Nov; 78(10):730-6. PubMed ID: 25708227
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype and survival in men and women with Alzheimer's disease.
Dal Forno G; Carson KA; Brookmeyer R; Troncoso J; Kawas CH; Brandt J
Neurology; 2002 Apr; 58(7):1045-50. PubMed ID: 11940690
[TBL] [Abstract][Full Text] [Related]
19. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease.
Lam LC; Tang NL; Ma SL; Lui VW; Chan AS; Leung PY; Chiu HF
Am J Alzheimers Dis Other Demen; 2006; 21(2):92-9. PubMed ID: 16634464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
